GLSI (STOCKS)
Greenwich LifeSciences, Inc.
$23.030000
-1.030000 (-4.28%)
Prev close: $24.060000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Snehal S. Patel
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $348.90M
- Employees
- 8
- P/E (TTM)
- -15.12
- P/B (TTM)
- 66.95
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
5
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.39 | $-0.34 | -0.0534 | -15.86% |
|
Dec 2025 (Q4)
|
$-0.58 | $-0.33 | -0.2536 | -77.70% |
|
Sep 2025 (Q3)
|
$-0.30 | $-0.30 | +0.0009 | +0.30% |
|
Jun 2025 (Q2)
|
$-0.30 | $-0.24 | -0.0552 | -22.55% |
Financial Statements
| Revenues | $0.00 |
| Operating Expenses | $22.40M |
| Research and Development | $20.16M |
| Other Operating Expenses | $2.25M |
| Operating Income/Loss | -$21.89M |
| Income/Loss From Continuing Operations After Tax | -$22.27M |
| Income/Loss From Continuing Operations Before Tax | -$22.27M |
| Net Income/Loss | -$22.27M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$22.27M |
| Net Income/Loss Available To Common Stockholders, Basic | -$21.04M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.61 |
| Diluted Earnings Per Share | -$1.61 |
| Basic Average Shares | 41,716,229 |
| Diluted Average Shares | 41,716,229 |
| Assets | $10.51M |
| Current Assets | $10.51M |
| Noncurrent Assets | $0.00 |
| Liabilities | $5.24M |
| Current Liabilities | $5.24M |
| Accounts Payable | $4.29M |
| Wages | $52.38K |
| Other Current Liabilities | $894.66K |
| Noncurrent Liabilities | $0.00 |
| Equity | $5.27M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $5.27M |
| Liabilities And Equity | $10.51M |
| Net Cash Flow From Financing Activities | $20.54M |
| Net Cash Flow From Financing Activities, Continuing | $20.54M |
| Net Cash Flow | $12.00M |
| Net Cash Flow, Continuing | $12.00M |
| Comprehensive Income/Loss | -$22.27M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$22.27M |
| Other Comprehensive Income/Loss | $0.00 |